{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:50:26Z","timestamp":1791341426666,"version":"4.3.1"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer US","isbn-type":[{"value":"9781071628102","type":"print"},{"value":"9781071628119","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2811-9_6","type":"book-chapter","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T19:04:33Z","timestamp":1670958273000},"page":"93-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Applications of Flow Cytometry in Cancer Immunotherapies: From Diagnosis to Treatments"],"prefix":"10.1007","author":[{"given":"Hemant K.","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"issue":"10","key":"6_CR1","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/eji.201970107","volume":"49","author":"A Cossarizza","year":"2019","unstructured":"Cossarizza A, Chang HD, Radbruch A et al (2019) Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur J Immunol 49(10):1457\u20131973. https:\/\/doi.org\/10.1002\/eji.201970107","journal-title":"Eur J Immunol"},{"issue":"Suppl 1","key":"6_CR2","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1002\/cyto.b.20364","volume":"72","author":"B Greig","year":"2007","unstructured":"Greig B, Oldaker T, Warzynski M et al (2007) 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometry. Cytometry B Clin Cytom 72(Suppl 1):S23\u2013S33. https:\/\/doi.org\/10.1002\/cyto.b.20364","journal-title":"Cytometry B Clin Cytom"},{"key":"6_CR3","doi-asserted-by":"publisher","unstructured":"Gaidano V, Tenace V, Santoro N et al (2020) A clinically applicable approach to the classification of B-cell non-Hodgkin lymphomas with flow cytometry and machine learning. Cancers (Basel) 12(6). https:\/\/doi.org\/10.3390\/cancers12061684","DOI":"10.3390\/cancers12061684"},{"issue":"2","key":"6_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/cyto.b.21724","volume":"96","author":"RK Grewal","year":"2019","unstructured":"Grewal RK, Chetty M, Abayomi EA et al (2019) Use of flow cytometry in the phenotypic diagnosis of Hodgkin\u2019s lymphoma. Cytometry B Clin Cytom 96(2):116\u2013127. https:\/\/doi.org\/10.1002\/cyto.b.21724","journal-title":"Cytometry B Clin Cytom"},{"issue":"6","key":"6_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/bcr1618","volume":"8","author":"MJ Beresford","year":"2006","unstructured":"Beresford MJ, Wilson GD, Makris A (2006) Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res 8(6):216. https:\/\/doi.org\/10.1186\/bcr1618","journal-title":"Breast Cancer Res"},{"key":"6_CR6","doi-asserted-by":"publisher","unstructured":"Kim KH, Sederstrom JM (2015) Assaying cell cycle status using flow cytometry. Curr Protoc Mol Biol 111:28.26.1\u201328.26.11. https:\/\/doi.org\/10.1002\/0471142727.mb2806s111","DOI":"10.1002\/0471142727.mb2806s111"},{"issue":"2","key":"6_CR7","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.4317\/medoral.18573","volume":"18","author":"R Bologna-Molina","year":"2013","unstructured":"Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N et al (2013) Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors. Med Oral Patol Oral Cir Bucal 18(2):e174\u2013e179. https:\/\/doi.org\/10.4317\/medoral.18573","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"7","key":"6_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1365-2559.2006.02430.x","volume":"48","author":"K Cho Mar","year":"2006","unstructured":"Cho Mar K, Eimoto T, Nagaya S et al (2006) Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid. Histopathology 48(7):801\u2013807. https:\/\/doi.org\/10.1111\/j.1365-2559.2006.02430.x","journal-title":"Histopathology"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1385\/1-59259-838-2:249","volume":"290","author":"J Stingl","year":"2005","unstructured":"Stingl J, Emerman JT, Eaves CJ (2005) Enzymatic dissociation and culture of normal human mammary tissue to detect progenitor activity. Methods Mol Biol 290:249\u2013263. https:\/\/doi.org\/10.1385\/1-59259-838-2:249","journal-title":"Methods Mol Biol"},{"key":"6_CR10","first-page":"doi:10.3791\/523","volume":"94","author":"S Garaud","year":"2014","unstructured":"Garaud S, Gu-Trantien C, Lodewyckx JN et al (2014) A simple and rapid protocol to non-enzymatically dissociate fresh human tissues for the analysis of infiltrating lymphocytes. J Vis Exp 94:doi:10.3791\/52392","journal-title":"J Vis Exp"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-7346-0_12","volume":"1678","author":"JD Tario Jr","year":"2018","unstructured":"Tario JD Jr, Conway AN, Muirhead KA et al (2018) Monitoring cell proliferation by dye dilution: considerations for probe selection. Methods Mol Biol 1678:249\u2013299. https:\/\/doi.org\/10.1007\/978-1-4939-7346-0_12","journal-title":"Methods Mol Biol"},{"key":"6_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711621","volume":"12","author":"HK Mishra","year":"2021","unstructured":"Mishra HK, Dixon KJ, Pore N et al (2021) Activation of ADAM17 by IL-15 limits human NK cell proliferation. Front Immunol 12:711621. https:\/\/doi.org\/10.3389\/fimmu.2021.711621","journal-title":"Front Immunol"},{"issue":"3","key":"6_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3109\/10428194.2015.1110748","volume":"57","author":"A Gafter-Gvili","year":"2016","unstructured":"Gafter-Gvili A, Polliack A (2016) Bendamustine associated immune suppression and infections during therapy of hematological malignancies. Leuk Lymphoma 57(3):512\u2013519. https:\/\/doi.org\/10.3109\/10428194.2015.1110748","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"6_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/2040620716681749","volume":"8","author":"AP Skarbnik","year":"2017","unstructured":"Skarbnik AP, Faderl S (2017) The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversies. Ther Adv Hematol 8(3):99\u2013105. https:\/\/doi.org\/10.1177\/2040620716681749","journal-title":"Ther Adv Hematol"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"6698969","DOI":"10.1155\/2021\/6698969","volume":"2021","author":"B Xenia Elena","year":"2021","unstructured":"Xenia Elena B, Nicoleta Gales L, Florina Zgura A et al (2021) Assessment of immune status in dynamics for patients with cancer undergoing immunotherapy. J Oncol 2021:6698969. https:\/\/doi.org\/10.1155\/2021\/6698969","journal-title":"J Oncol"},{"issue":"1\u20132","key":"6_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jim.2007.05.011","volume":"325","author":"KS Chan","year":"2007","unstructured":"Chan KS, Kaur A (2007) Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T lymphocytes in rhesus macaques. J Immunol Methods 325(1\u20132):20\u201334. https:\/\/doi.org\/10.1016\/j.jim.2007.05.011","journal-title":"J Immunol Methods"},{"issue":"9","key":"6_CR17","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00262-018-2193-1","volume":"67","author":"HK Mishra","year":"2018","unstructured":"Mishra HK, Pore N, Michelotti EF et al (2018) Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNgamma production by human NK cells in the presence of antibody-bound tumor cells. Cancer Immunol Immunother 67(9):1407\u20131416. https:\/\/doi.org\/10.1007\/s00262-018-2193-1","journal-title":"Cancer Immunol Immunother"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1479-5876-10-29","volume":"10","author":"Z Zheng","year":"2012","unstructured":"Zheng Z, Chinnasamy N, Morgan RA (2012) Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry. J Transl Med 10:29. https:\/\/doi.org\/10.1186\/1479-5876-10-29","journal-title":"J Transl Med"},{"issue":"3","key":"6_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057838","volume":"8","author":"B Jena","year":"2013","unstructured":"Jena B, Maiti S, Huls H et al (2013) Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials. PLoS One 8(3):e57838. https:\/\/doi.org\/10.1371\/journal.pone.0057838","journal-title":"PLoS One"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3389\/fimmu.2020.01770","volume":"11","author":"Y Hu","year":"2020","unstructured":"Hu Y, Huang J (2020) The chimeric antigen receptor detection toolkit. Front Immunol 11:1770. https:\/\/doi.org\/10.3389\/fimmu.2020.01770","journal-title":"Front Immunol"},{"issue":"1","key":"6_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40164-020-00190-2","volume":"9","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhao P, Huang H (2020) Engineering better chimeric antigen receptor T cells. Exp Hematol Oncol 9(1):34. https:\/\/doi.org\/10.1186\/s40164-020-00190-2","journal-title":"Exp Hematol Oncol"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3389\/fimmu.2020.01217","volume":"11","author":"S Arcangeli","year":"2020","unstructured":"Arcangeli S, Falcone L, Camisa B et al (2020) Next-generation manufacturing protocols enriching TSCM CAR T cells can overcome disease-specific T cell defects in cancer patients. Front Immunol 11:1217. https:\/\/doi.org\/10.3389\/fimmu.2020.01217","journal-title":"Front Immunol"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","volume":"6","author":"W Wang","year":"2015","unstructured":"Wang W, Erbe AK, Hank JA et al (2015) NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy. Front Immunol 6:368. https:\/\/doi.org\/10.3389\/fimmu.2015.00368","journal-title":"Front Immunol"},{"issue":"7","key":"6_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.tibtech.2017.12.008","volume":"36","author":"M Doan","year":"2018","unstructured":"Doan M, Vorobjev I, Rees P et al (2018) Diagnostic potential of imaging flow cytometry. Trends Biotechnol 36(7):649\u2013652. https:\/\/doi.org\/10.1016\/j.tibtech.2017.12.008","journal-title":"Trends Biotechnol"}],"container-title":["Methods in Molecular Biology","Signal Transduction Immunohistochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2811-9_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T19:06:49Z","timestamp":1670958409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2811-9_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"ISBN":["9781071628102","9781071628119"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2811-9_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"assertion":[{"value":"14 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}